Degnan Chris
Reporting owner on Forms 3, 4 and 5, CIK 1741968.
Degnan Chris reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-09.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| URGN · UroGen Pharma Ltd.CIK 1668243 | officer (Chief Financial Officer) | 1 | 2026-10-09 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| URGN · UroGen Pharma Ltd.Ordinary Shares | 2026-10-08 | M exercised | +4,483 | 6,763 | Form 4 | |
| URGN · UroGen Pharma Ltd.Ordinary Shares | 2026-10-08 | S sold | -2,202 | $36.69 | 4,561 | Form 4 |
| URGN · UroGen Pharma Ltd.Restricted Stock Units, derivative | 2026-10-08 | M exercised | -4,483 | $0 | 4,484 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001437749-26-032421 | UroGen Pharma Ltd. | 2026-10-09 |